3P innovation's cryoFIL™' wins Medilink Midlands Business Award for 'Excellence in Innovation'.

3P innovation wins Medilink Midlands Innovation Award for cryoFIL™

3P innovation is delighted to announce that our cryoFIL™ platform has been awarded the Medilink Midlands Award for Innovation, recognising excellence in pioneering technologies that support the future of healthcare.

As an employee-owned business, this accolade is a testament to the ingenuity, dedication, and collaborative spirit of our engineering teams, who continue to push the boundaries of what's possible in advanced manufacturing. cryoFIL™ represents a critical step forward in the industrialisation of cell and gene therapy - delivering scalable, automated solutions that help bring life-changing treatments to more patients, faster.

Automation plays a pivotal role in making novel therapies accessible, reliable, and economically viable. At 3P, we’re proud to be driving innovation in this space, partnering with global pharma and CDMOs to accelerate therapeutic breakthroughs from lab to patient.

We would like to extend our sincere thanks to Medilink Midlands for this recognition and to Walk Through Walls for sponsoring the award. Congratulations to all the outstanding finalists.

cryoFIL®cryovial filling platform

In the rapidly growing Cell & Gene Therapy (CGT) sector, many processes remain manual, raising contamination risks from operator handling. The cryoFIL^® system automates your cryovial filling process and uses Controlled Rate Freezer (CRF) compatible racks, providing seamless integration. From small to large batch sizes - whether 10 or 1000 vials - we comply with current regulatory standards to offer a scalable solution for your cell therapy needs.

READ MORE